JPH0137377B2 - - Google Patents

Info

Publication number
JPH0137377B2
JPH0137377B2 JP14914683A JP14914683A JPH0137377B2 JP H0137377 B2 JPH0137377 B2 JP H0137377B2 JP 14914683 A JP14914683 A JP 14914683A JP 14914683 A JP14914683 A JP 14914683A JP H0137377 B2 JPH0137377 B2 JP H0137377B2
Authority
JP
Japan
Prior art keywords
vitamin
combination
blood
effect
alloxan
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP14914683A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6041611A (ja
Inventor
Kazuo Hasegawa
Mitsuharu Iwamoto
Yoichi Matsushita
Mitsuo Yamazaki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Priority to JP14914683A priority Critical patent/JPS6041611A/ja
Publication of JPS6041611A publication Critical patent/JPS6041611A/ja
Publication of JPH0137377B2 publication Critical patent/JPH0137377B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP14914683A 1983-08-17 1983-08-17 血中脂質低下剤 Granted JPS6041611A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14914683A JPS6041611A (ja) 1983-08-17 1983-08-17 血中脂質低下剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14914683A JPS6041611A (ja) 1983-08-17 1983-08-17 血中脂質低下剤

Publications (2)

Publication Number Publication Date
JPS6041611A JPS6041611A (ja) 1985-03-05
JPH0137377B2 true JPH0137377B2 (enEXAMPLES) 1989-08-07

Family

ID=15468773

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14914683A Granted JPS6041611A (ja) 1983-08-17 1983-08-17 血中脂質低下剤

Country Status (1)

Country Link
JP (1) JPS6041611A (enEXAMPLES)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2547400B2 (ja) * 1986-02-27 1996-10-23 昭和電工株式会社 動物用薬剤
JP3283274B2 (ja) * 1991-06-15 2002-05-20 サントリー株式会社 新規組成物
CN1250212C (zh) * 2000-10-23 2006-04-12 三共株式会社 血中脂类改善剂组合物
US6916849B2 (en) 2000-10-23 2005-07-12 Sankyo Company, Limited Compositions for improving lipid content in the blood
AU2002211005A1 (en) 2000-11-07 2002-05-21 Sankyo Company Limited Lipid peroxide-lowering compositions
US7037934B2 (en) 2000-12-14 2006-05-02 Sankyo Company, Limited Blood lipid ameliorant composition
WO2002047683A1 (fr) * 2000-12-14 2002-06-20 Sankyo Company, Limited Composition ameliorant les lipides dans le sang
CA2433285C (en) 2000-12-14 2009-06-23 Sankyo Company, Limited Blood lipid ameliorating composition
TWI284529B (en) * 2000-12-18 2007-08-01 Sankyo Co A composition for lowering triglyceride
AU2003257778A1 (en) * 2002-08-02 2004-02-23 Shenzhen Salubris Pharmaceuticals Co., Ltd. A riboflavin derivative and its manufacture and uses

Also Published As

Publication number Publication date
JPS6041611A (ja) 1985-03-05

Similar Documents

Publication Publication Date Title
JPS60109522A (ja) 神経病の治療のためのビロバリド含有製剤組成物
IE60923B1 (en) Pharmaceutical composition for oral administration, based on a diphosphonic acid derivative
JP2010533168A (ja) ユビデカレノンを含有する多層錠ビタミン複合製剤
JP2881442B2 (ja) ジルチアゼムの遅放出性無酸医薬製剤及びその製法
AT400521B (de) Verfahren zur herstellung einer festen oralen pharmazeutischen ketotifenzusammensetzung
JPH11514629A (ja) 安定な甲状腺ホルモン含有薬剤
IL102519A (en) Oral dosage formulations of dideoxy purine nucleosides containing water insoluble antacid buffers
JPH0137377B2 (enEXAMPLES)
WO2011152875A1 (en) Chewable, swallowable and effervescent solid dosge form for oral delivery of pharmaeutical actives
EP0521057B1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
Stolk et al. Serum levels of 8‐methoxypsoralen: difference between two oral methods of administration
UA74793C2 (en) Bioavailable pharmaceutical composition of isotretinoin and process for preparing such composition
US3928609A (en) Non-alcoholic theophylline product
JPH04295428A (ja) 抗アレルギー剤
US5504105A (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
JPH05255126A (ja) 苦味低減組成物
TW202128150A (zh) ３＇—［（２ｚ）—［１—（３，４—二甲基苯基）—１，５—二氫—３—甲基—５—側氧基—４ｈ—吡唑—４—亞基］肼基］—２＇—羥基—［１，１＇—聯苯基］—３—甲酸及其鹽配製物
JP3035328B2 (ja) 血中脂質低下剤
JPS5824514A (ja) 消化性潰瘍治療剤
US3891749A (en) Digestive pharmaceutical composition comprising S-carboxymethyl cysteine for reducing viscosity of respiratory tract secretions, and method of treating therewith
US4146648A (en) Chemotherapeutic composition
US3574834A (en) Medicinal soporific composition
JP2000080034A (ja) 風邪用組成物
JP7451124B2 (ja) 内服組成物およびその吸湿抑制方法
Summers et al. The bioavailability, absorption characteristics and formulation of four commercially-available controlled-release theophylline products